Moving with the times
The troy ounce of gold currently costs just under 1230 US dollars. Calculated in euros, around 1062 euros have to be paid. The gold price in US dollars has just crossed the important 100-day line (around 1227 US dollars). If this remains so, then further purchases are to be expected. One of the causes at present is certainly Italy's problems with the draft budget, which contains a high deficit for 2019 and is likely to receive disapproval from the EU.
Gold and silver are of course still in demand as investments, jewellery and as a means of preserving value. In these times of low interest rate policy and political uncertainty, anyone who wants to preserve or even increase their assets should look around solid gold companies. These include Osisko Gold Royalties - https://www.commodity-tv.net/c/search_adv/?v=298621, a precious metals investment company. An investment in the company gives you a stake in the portfolio, which includes more than 130 royalties, streams and precious metal purchases.
A hemp business is surely still a novelty between bakery and hairdresser, which is viewed with some astonishment. Even if hemp is only contained in very small doses in the products. But if you look at the global marijuana situation, the treatment of serious diseases with the drug is on the rise. In Canada, even recreational use has been legalised since 17 October 2018. And so, in the cannabis sector, there are also a number of stock corporations with which investors can earn money - provided they bet on the right horse.
An interesting cannabis company is RavenQuest BioMed - https://www.commodity-tv.net/c/search_adv/?v=298617. The production of cannabis, as well as research and development belong to the company profile. A research partnership exists between McGill University in Montreal and society. The annual production target is 7000 kilograms of cannabis. Particular attention will be paid to maximising the effective use of space in the cannabis production facilities.
Current company information and press releases from Osisko Gold Royalties (https://www.resource-capital.ch/en/companies/osisko-gold-royalties-ltd.html) and RavenQuest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc.html).
In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the English version of these messages applies.
Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: www.resource-capital.ch/en/disclaimer.html